Daniela Kroshinsky MD, MPHAssociate Professor of Dermatology, Harvard Medical School; Director of Inpatient Dermatology and Director of Pediatric Dermatology, Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts
Daniela Kroshinsky, MD, MPH, graduated summa cum laude from Northwestern University Honors Program in Medical Education, where she received her Medical Degree and was inducted to the Alpha Omega Alpha Honor Society. She received her Masters of Public Health from the Harvard School of Public Health. She completed her internship at Yale-New Haven Hospital where she received the Preliminary Intern of the Year award and her residency training at SUNY Downstate University where she served as Chief Resident. Dr. Kroshinsky is a board-certified dermatologist at the Massachusetts General Hospital and MassGeneral Hospital for Children, where she serves as the Director of Inpatient Dermatology and the Director of Pediatric Dermatology. She specializes in complex medical dermatology in the outpatient and hospital setting. She is an Associate Professor of Dermatology at Harvard Medical School where she greatly enjoys teaching. She is past-President of the Medical Dermatology Society and President-elect of the Society of Dermatology Hospitalists. She is an active researcher and has been awarded the several research grants, resulting in the authorship of over 140 peer reviewed medical publications and invitations to speak nationally and internationally on her findings.
Recent Contributions to PracticeUpdate:
- Association of Rituximab With the Risk of Long-Term Cardiovascular and Metabolic Outcomes in Patients With Pemphigus
- Cutaneous Immune-Related Adverse Events Are Associated With Increased Survival in Patients Treated With Anti-PD-1 and Anti-PD-L1 Therapy
- Use of Dermatology Services Among Various Demographic and Socioeconomic Strata in the United States
- Clinical Characteristics Associated With Days to Discharge Among Patients Admitted With Lower Limb Cellulitis
- Rituximab Therapy Safe and Effective for Treatment of Pemphigus Vulgaris